The prostate cancer drugs market is expected to nearly double by 2020, due to the introduction of new, more expensive drugs.

PUNE, INDIA, December 19, 2016 /EINPresswire.com/ -- Global Prostate Cancer Therapeutics Market

Global Prostate Cancer Therapeutics Industry Overview

The prostate cancer drugs market is expected to nearly double by 2020, due to the introduction of new, more expensive drugs. Prostate Cancer is the most frequently diagnosed cancer in men. In terms of loss of life from any disease, prostate cancer ranks eleventh; and it ranks sixth in terms of cancer–related mortality in men. The prostate cancer market has a huge demand for new and novel drugs that address unmet needs such as improved survival time, less toxicity, increased progression free survival, increased effectiveness, and lower cost. The global market for the prostate cancer therapeutics market is increasing, driven primarily by the growth in the hormone–refractory prostate cancer therapeutics market. Although, the prostate cancer market faces some hindrances such as the high cost of prostate cancer drugs, the market for prostate cancer drugs is likely to rise in the future.

Try Sample Report @ https://www.wiseguyreports.com/sample-request/526410-virtual-reality-market-hardware-head-mounted-healthcare-global-analysis

Global Prostate Cancer Drugs Analysis: Zytiga was the leading prostate cancer drugs in 2014 being followed by Xtandi drugs. In prostate cancer drugs market, Leuplin and Zoladex stand at the third and fourth position respectively in 2014, while Lupron stands at the fifth position in the same year. Bayer's cancer drug Xofigo is also increasing its market share. Decapeptyl, Taxotere, Jevtana and Provenge are the other popular prostate cancer drugs in the global market.

Renub Research report titled “Global Prostate Cancer Therapeutics Market to 2020” provides a comprehensive assessment of the fast–evolving, high–growth of Prostate Cancer Therapeutics Market. This 80 page report with 35 Figures and 2 Tables analyses the Prostate Cancer Therapy Drugs Market, driving factors and challenges for prostate cancer market landscape.

Buy this report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=529588

The report covers the following:

1. Global Prostate Cancer – Hormonal Therapy Drugs Market

Luteinizing Hormone–Releasing Hormone (LHRH) Antagonists
Zytiga
2. Gonax
Luteinizing Hormone–Releasing Hormone (LHRH) Analogs
Lupron
2. Zoladex
3. Decapeptyl
4. Eligard
5. Vantas
6. Leuplin
Anti–Androgens
1. Casodex
2. Xtandi or MDV3100
3. Xtandi US or MDV3100
Global Prostate Cancer Chemotherapy Drugs Market
Taxotere
2. Jevtana
Global Prostate Cancer Immunotherapy Drugs Market
Provenge
Global Prostate Cancer Targeted Therapy Drugs Market
Xofigo or Alpharadin

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non–printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/529588-global-prostate-cancer-therapeutics-market-to-2020

Major Points from Table of content:

1. Executive Summary

2. Prostate Cancer – Overview
2.1 Prostate Cancer Introduction
2.2 Risk Factors
2.2.1 Age
2.2.2 Race
2.2.3 Family History/Genetics
2.2.4 Diet/Lifestyle Factors
2.2.5 Obesity
2.2.6 Infection/Inflammation of the Prostate Gland
2.3 Disease Symptoms
2.4 Diagnosis
2.4.1 Digital Rectal Exam (DRE)
2.4.2 Prostate Specific Antigen (PSA) Blood Test
2.4.3 Prostate Ultrasound and Biopsy
2.4.4 Bone Scan
2.4.5 CT Scan & MRI
2.4.6 PET & SPECT Scan
2.4.7 Lymph Node Biopsy
2.4.8 ProstaScint Scan
2.5 Stages of Prostate Cancer
2.5.1 Stage I
2.5.2 Stage II
2.5.3 Stage III
2.5.4 Stage IV

3. Global Prostate Cancer Drugs Market

...CONTINUED

For more information or any query mail at sales@wiseguyreports.com

About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.